Literature DB >> 17043177

Are drug-eluting stents cost-effective? It depends on whom you ask.

Jason Ryan1, David J Cohen.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17043177     DOI: 10.1161/CIRCULATIONAHA.105.546010

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

1.  Concurrent drug eluting/bare metal stent implantation during percutaneous coronary intervention in target vessel: outcomes and 1-year follow-up.

Authors:  Alessandro Cuneo; Peter Bramlage; Matthias Hochadel; Jochen Senges; Christoph Nienaber; Karl-Heinz Kuck; Ulrich Tebbe
Journal:  Clin Res Cardiol       Date:  2011-12-09       Impact factor: 5.460

2.  Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstream vascular resistance in obese and diabetic rats.

Authors:  Hongfeng Wang; Dorothee Weihrauch; Judy R Kersten; Jeffrey M Toth; Anthony G Passerini; Anita Rajamani; Sonja Schrepfer; John F LaDisa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

Review 3.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

Review 4.  A systematic review of the quality of economic models comparing thrombosis inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Maximilian H M Hatz; Reiner Leidl; Nichola A Yates; Björn Stollenwerk
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

5.  Overview of Technical and Cost Considerations in Complex Percutaneous Coronary Intervention.

Authors:  J Raider Estrada; Jonathan D Paul; Atman P Shah; Sandeep Nathan
Journal:  Interv Cardiol       Date:  2014-03

Review 6.  Another view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention.

Authors:  Neil J Wimmer; Robert W Yeh
Journal:  Trends Cardiovasc Med       Date:  2012-07-28       Impact factor: 6.677

Review 7.  Bioresorbable scaffolds for percutaneous coronary interventions.

Authors:  Bill D Gogas
Journal:  Glob Cardiol Sci Pract       Date:  2014-12-31

8.  Impact of hospital and sociodemographic factors on utilization of drug-eluting stents in 2011-2012 Medicare cohort.

Authors:  Tushar A Tuliani; Maithili Shenoy; Milind Parikh; Mauricio G Cohen; Cindy Grines; Kenneth Jutzy; Anthony Hilliard
Journal:  Avicenna J Med       Date:  2017 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.